Back to Trades
Oltmans Curtis Gale
InsiderCIK 0001714982
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Oltmans Curtis Gale has filed 2 SEC reports (2025–2026), all concentrated in Fulcrum Therapeutics, Inc. (FULC), totaling $1.9M in disclosed volume. Weighing $0 bought versus $44.6K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 4 | FULC Fulcrum Therapeutics, Inc. | Oltmans Curtis Gale | Insider | Award | $1.8M |
| Dec 17 | FULC Fulcrum Therapeutics, Inc. | Oltmans Curtis Gale | Insider | Sell | $44.6K |
2 filings